HomeCONGRESS

CONGRESS

ACC 2021 | TALOS-AMI: De-escalating from Ticagrelor to Clopidogrel after One Month

After one-month dual antiplatelet therapy (DAPT) with aspirin and ticagrelor, a net clinical benefit was observed when...

ACC 2021 | Relive Renal Denervation with RADIANCE-HTN TRIO

Endovascular ultrasound renal denervation significantly reduces systolic blood pressure when compared against a sham procedure according to...

ACC 2021 | Sacubitril/Valsartan not Superior to Ramipril after AMI

The combination sacubitril/valsartan following high-risk AMI did not reduce the risk of cardiac failure or cardiovascular risk in...

ACC 2021 | Emergent CABG for acute MI: Benefits Despite Risk

The latest figures show a lower number of emergency CABG for acute MI, and in turn increased...

ACC 2021 | LAAOS III: Appendage Closure During Central Vascular Surgery

According to the LAAOS III study, presented at the American College of Cardiology (ACC) 2021 Congress and simultaneously...

ACC 2021 | Stress Increases Events in Young Patients with Prior MI

Young or middle-aged patients who have already suffered a heart attack have almost twice as many adverse...

ACC 2021

Here are the most important scientific articles of the ACC 2021 virtual Congress. If you cannot view the...

Discount for SOLACI Members – V Heart Failure Review 2020

On December 7 thru 12 SOLACI is holding the 5th International Round of Conferences 2020 on “Heart...